Waystar to Present at J.P. Morgan Healthcare Conference

Rhea-AI Summary

Waystar (NASDAQ: WAY) announced that CEO Matt Hawkins will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 11:15 a.m. PT.

The company said it will provide a live webcast of the presentation on its Investor Relations site at https://investors.waystar.com/news-events/events, and that a recording will be available on the site after the event.

Key Figures

Conference edition 44th Annual J.P. Morgan Healthcare Conference

Presentation date January 12, 2026 Waystar CEO presentation at J.P. Morgan Healthcare Conference

Presentation time 11:15 a.m. PT Scheduled time of J.P. Morgan Healthcare Conference presentation

Market Reality Check

$31.78 Last Close

Volume Volume 605,216 is about 0.25x the 20-day average of 2,374,123, indicating muted trading ahead of the conference. low

Technical Shares at $32.98 are trading below the 200-day MA of $37.15 and about 31.45% under the 52-week high.

Peers on Argus

Peers show mixed moves: HQY +1.28%, PRVA +1.77%, DOCS +0.34%, PINC +0.07%, while BTSG -0.29%. With WAY roughly flat (-0.09%) and no momentum signals, trading appears stock-specific rather than a coordinated sector move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 18	Investor conferences	Positive	+1.7%	CEO and CFO participation in multiple early December investor conferences.
Nov 18	Index inclusion	Positive	+1.7%	Announcement of joining S&P SmallCap 600 and highlighting growth metrics.
Oct 29	Earnings results	Positive	+0.3%	Q3 2025 beat with higher revenue, margins, and raised full‑year guidance.
Oct 15	Leadership update	Neutral	+0.3%	RIS Rx appoints chairman who also serves as Waystar’s independent chairman.
Oct 14	Earnings announcement	Neutral	+0.3%	Scheduling and access details for upcoming Q3 2025 earnings release.

Pattern Detected

Recent news, including index inclusion, strong Q3 results, and conference participation, has generally seen modestly positive price reactions, with no instances of negative reactions in the last five events.

Recent Company History

Over the past few months, Waystar reported stronger Q3 2025 results on Oct 29, 2025, with revenue of $268.7M and raised full‑year guidance. The company also announced S&P SmallCap 600 inclusion with metrics like $1.8T in gross claims processed and 115% net revenue retention. Management has been active at multiple investor conferences in November and December. Today’s J.P. Morgan Healthcare Conference presentation continues this pattern of investor outreach following operational and index-related milestones.

Regulatory & Risk Context

Active S-3 Shelf Registration 2025-07-14

The company has an effective S-3ASR shelf filed on 2025-07-14, expiring on 2028-07-14. It has been used at least once, as indicated by a 424B7 filing on 2025-09-11, providing flexibility to issue securities when needed.

Market Pulse Summary

This announcement highlights Waystar’s participation in the J.P. Morgan Healthcare Conference on January 12, 2026, extending a recent cadence of investor outreach that included multiple December conferences and strong Q3 2025 results with revenue of $268.7M. Investors may track how management frames integration of recent acquisitions, capital structure moves disclosed in the 10-Q, and the flexibility afforded by the effective S-3ASR. Monitoring future earnings updates and additional SEC filings will be important.

AI-generated analysis. Not financial advice.

LEHI, Utah and LOUISVILLE, Ky., Dec. 29, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will present at the 44^th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 11:15 a.m. PT.

Waystar will provide a live webcast of the presentation on its Investor Relations website at https://investors.waystar.com/news-events/events. A recording will also be available on the site after the event.

About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Media Contact 
Kristin Lee
kristin.lee@waystar.com 

Investor Contact
Sue Dooley
susan.dooley@waystar.com  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-to-present-at-jp-morgan-healthcare-conference-302650029.html

SOURCE Waystar

FAQ

When will Waystar (NASDAQ: WAY) present at the J.P. Morgan Healthcare Conference?

Waystar will present on January 12, 2026 at 11:15 a.m. PT.

Who from Waystar will speak at the January 12, 2026 presentation (WAY)?

Chief Executive Officer Matt Hawkins will present.

How can investors watch Waystar's (WAY) J.P. Morgan presentation live?

The presentation will be live webcast on Waystar's Investor Relations site at https://investors.waystar.com/news-events/events.

Will Waystar (WAY) make a recording of the J.P. Morgan presentation available?

Yes. A recording will be posted on the company's Investor Relations website after the event.

What is the J.P. Morgan Healthcare Conference date and relevance for Waystar (WAY)?

The conference runs in January; Waystar's presentation is scheduled for January 12, 2026 and provides an investor update forum.

Where can I find the webcast and recording of Waystar's (WAY) presentation after January 12, 2026?

Both the live webcast and the recording will be available at https://investors.waystar.com/news-events/events.